Each ampoule (2 mL) contains: Monosialotetrahexosylganglioside Sodium (as the sodium salt) – 20 mg
Monosialotetrahexosylganglioside sodium (GM1 sodium) exhibits a high affinity for nervous tissue, enabling it to selectively interact with neuronal cells and directly influence their physiological functions. Exogenously administered monosialotetrahexosylganglioside sodium is capable of crossing the blood-brain barrier. Following administration, it integrates into neuronal cell membranes, where it contributes to membrane stabilization, neuronal repair, and modulation of cellular functions involved in nerve regeneration and neuroprotection.
Indications
Monosialotetrahexosylganglioside sodium is indicated for the treatment of disorders and injuries affecting the central and peripheral nervous systems, including:
- Traumatic brain injury;
- Spinal cord injury;
- Cerebrovascular disorders (including impairment of cerebral circulation);
- Neurodegenerative diseases, such as Parkinson’s disease.